Subject Characteristics
| Subject no. | Sex | Age (y) | DSM-IV | Onset first psychosis | No. of psychoses | Positive PANSS | Negative PANSS | Global PANSS | Antipsychotic |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers | |||||||||
| 1 | F | 27 | – | – | – | – | – | – | – |
| 2 | F | 39 | – | – | – | – | – | – | – |
| 3 | F | 23 | – | – | – | – | – | – | – |
| 4 | M | 23 | – | – | – | – | – | – | – |
| 5 | M | 24 | – | – | – | – | – | – | – |
| 6 | M | 22 | – | – | – | – | – | – | – |
| 7 | M | 30 | – | – | – | – | – | – | – |
| 8 | M | 27 | – | – | – | – | – | – | – |
| Patients | |||||||||
| 1 | M | 28 | 295.30 | 21 | 4 | 20 | 21 | 40 | Olanzapine |
| 2 | M | 42 | 298.90 | 26 | 2 | 20 | 10 | 28 | Zuclopentixol |
| 3 | F | 40 | 295.30 | 40 | 1 | 19 | 18 | 37 | Olanzapine |
| 4 | M | 28 | 295.30 | 26 | 1 | 18 | 19 | 42 | Haloperidol |
| 5 | M | 31 | 295.30 | 29 | 1 | 21 | 19 | 37 | Risperidone |
| 6 | M | 28 | 295.30 | 20 | 2 | 25 | 20 | 47 | Risperidone |
| 7 | M | 22 | 298.90 | 20 | 2 | 15 | 9 | 30 | Risperidone |